Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial
Background: Animal studies suggest that undercarboxylated osteocalcin may improve insulin sensitivity via its effect on testicular testosterone production. Human studies have been conflicting. Men undergoing androgen deprivation therapy (ADT) for prostate cancer experience profound hypogonadism resu...
Main Authors: | Ada S. Cheung, Rudolf Hoermann, Jasmine Zhu, Daryl Lim Joon, Jeffrey D. Zajac, Mathis Grossmann |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188211012118 |
Similar Items
-
Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy
by: Ippei Kojima, et al.
Published: (2019-12-01) -
Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
by: Matthew E. Johnson, et al.
Published: (2012-01-01) -
Risk of Comorbidities in Advanced Prostate Cancer Patients Receiving Androgen Deprivation Therapy
by: Olivia Rachel Hwang, et al.
Published: (2018) -
Lacrimal sac adenocarcinoma managed with androgen deprivation
by: David H. Abramson, et al.
Published: (2020-09-01) -
Using Switching Linear Systems to Reach a Prespecified Traget
by: A. Benmerzouga
Published: (1997-12-01)